Introduction: The role of tea consumption on rheumatoid arthritis (RA) has been studied in recent years, but no clear conclusion has been drawn as a result of small sample size of the studies or the fact that only in vitro studies have been performed. Objectives: The aim of this study was to explore the possible association of tea consumption with RA through a large-scale, real-world study. Methods: A total of 733 RA patients were investigated from June to December, 2016. The disease activity of RA was assessed according to disease activity score 28-erythrocyte sedimentation rate. The amount and types of tea consumption were recorded by on-site self-administered questionnaires. Logistic regression models were applied to analyze the correlation between tea consumption and disease activity, adjusting for demographics, clinical and laboratory factors. Results: There was an inverse association between tea consumption and disease activity in RA patients (OR 0.66, 95% CI 0.46–0.94). Compared with non-tea drinkers, a higher-intake of tea (>750 mL/day) was associated with lower disease activity of RA (OR 0.39, 95% CI 0.19–0.79), but not low-intake (≤750 mL/day; OR 0.83, 95% CI 0.42–1.63). A significant dose-response association was found between the amount of tea consumption and disease activity (p for trend <0.01). Further hierarchical regression analysis showed that such inverse associations were mainly present in female patients (p = 0.004), non-smokers (p = 0.01) or elders (≥60 years; p = 0.01). Conclusion: Tea consumption is associated with decreased disease activity of RA, suggesting the potential beneficial effect of tea in the disease.

Møller-Bisgaard S, Hørslev-Petersen K, Ejbjerg B, Hetland ML, Ørnbjerg LM, Glinatsi D, et al. Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.
. 2019 Feb;321(5):461–72.
Boeters DM, Burgers LE, Toes RE, van der Helm-van Mil A. Does immunological remission, defined as disappearance of autoantibodies, occur with current treatment strategies? A long-term follow-up study in rheumatoid arthritis patients who achieved sustained DMARD-free status.
Ann Rheum Dis
. 2019 Nov;78(11):1497–504.
McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis.
. 2017 Jun;389(10086):2328–37.
Aletaha D, Smolen JS. Diagnosis and Management of Rheumatoid Arthritis: A Review.
. 2018 Oct;320(13):1360–72.
Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM. Genetic and environmental risk factors for rheumatoid arthritis.
Best Pract Res Clin Rheumatol
. 2017 Feb;31(1):3–18.
Brody H. Tea.
. 2019 Feb;566(7742):S1.
Chen F, He BC, Yan LJ, Liu FP, Huang JF, Hu ZJ, et al. Tea consumption and its interactions with tobacco smoking and alcohol drinking on oral cancer in southeast China.
Eur J Clin Nutr
. 2017 Apr;71(4):481–5.
Thielecke F, Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome - a review.
. 2009 Jan;70(1):11–24.
Rambod M, Nazarinia M, Raieskarimian F. The impact of dietary habits on the pathogenesis of rheumatoid arthritis: a case-control study.
Clin Rheumatol
. 2018 Oct;37(10):2643–8.
Alghadir AH, Gabr SA, Al-Eisa ES. Green tea and exercise interventions as nondrug remedies in geriatric patients with rheumatoid -arthritis.
J Phys Ther Sci
. 2016 Oct;28(10):2820–9.
de Mejia EG, Ramirez-Mares MV, Puangpraphant S. Bioactive components of tea: cancer, inflammation and behavior.
Brain Behav Immun
. 2009 Aug;23(6):721–31.
Wu PH, Lin SK, Lee BS, Kok SH, Wang JH, Hou KL, et al. Epigallocatechin-3-gallate diminishes cytokine-stimulated Cyr61 expression in human osteoblastic cells: a therapeutic potential for arthritis.
Rheumatology (Oxford)
. 2012 Nov;51(11):1953–65.
Rothenberg DO, Zhang L. Mechanisms Underlying the Anti-Depressive Effects of Regular Tea Consumption.
. 2019 Jun;11(6):11.
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/-European League Against Rheumatism collaborative initiative.
Arthritis Rheum
. 2010 Sep;62(9):2569–81.
Yang YC, Lu FH, Wu JS, Wu CH, Chang CJ. The protective effect of habitual tea consumption on hypertension.
Arch Intern Med
. 2004 Jul;164(14):1534–40.
van der Heijde DM, van ’t Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.
Ann Rheum Dis
. 1990 Nov;49(11):916–20.
Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire.
Arthritis Rheum
. 1983 Nov;26(11):1346–53.
Lamers-Karnebeek FB, Jacobs JW, Radstake TR, van Riel PL, Jansen TL. Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activity.
Rheumatology (Oxford)
. 2019 Mar;58(3):427–31.
Park SY, Freedman ND, Haiman CA, Le Marchand L, Wilkens LR, Setiawan VW. Association of Coffee Consumption With Total and Cause-Specific Mortality Among Nonwhite Populations.
Ann Intern Med
. 2017 Aug;167(4):228–35.
Wasserman AM. Diagnosis and management of rheumatoid arthritis.
Am Fam Physician
. 2011 Dec;84(11):1245–52.
Ghavipour M, Sotoudeh G, Tavakoli E, Mowla K, Hasanzadeh J, Mazloom Z. Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients.
Eur J Clin Nutr
. 2017 Jan;71(1):92–6.
Hoensch H, Oertel R. [Anti-inflammatory effects of tea-flavonoids].
Dtsch Med Wochenschr
. 2012 Dec;137(51-52):2738–40.
Ahmed S, Marotte H, Kwan K, Ruth JH, Campbell PL, Rabquer BJ, et al. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production.
Proc Natl Acad Sci USA
. 2008 Sep;105(38):14692–7.
Liu D, Li P, Song S, Liu Y, Wang Q, Chang Y, et al. Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis.
Eur J Pharmacol
. 2012 Sep;690(1-3):214–25.
Min SY, Yan M, Kim SB, Ravikumar S, Kwon SR, Vanarsa K, et al. Green Tea Epigallocatechin-3-Gallate Suppresses Autoimmune Arthritis Through Indoleamine-2,3-Dioxygenase Expressing Dendritic Cells and the Nuclear Factor, Erythroid 2-Like 2 Antioxidant Pathway.
J Inflamm (Lond)
. 2015 Sep;12(1):53.
Liu ZS, Cai H, Xue W, Wang M, Xia T, Li WJ, et al. G3BP1 promotes DNA binding and activation of cGAS.
Nat Immunol
. 2019 Jan;20(1):18–28.
Yang Y, Zhang T. Antimicrobial Activities of Tea Polyphenol on Phytopathogens: A Review.
. 2019 Feb 25;24(4). pii: E816.
Calis Z, Mogulkoc R, Baltaci AK. The roles of Flavonoles/Flavonoids in Neurodegeneration and Neuroinflammation.
Mini Rev Med Chem
. 2019 Jun; Epub ahead of print.
Xu J, Xu Z, Zheng W. A Review of the Antiviral Role of Green Tea Catechins.
. 2017 Aug;22(8):22.
Yu Y, Lyu S, Chen D, Lin Y, Chen J, Chen G, et al. Volatiles Emitted at Different Flowering Stages of Jasminum sambac and Expression of Genes Related to α-Farnesene Biosynthesis.
. 2017 Mar;22(4):546.
Yin Y, Ying X, Luan H, Zhao Z, Lou J, Wang D, et al. UPLC-DAD/Q-TOF-MS Based Ingredients Identification and Vasorelaxant Effect of Ethanol Extract of Jasmine Flower.
Evid Based Complement Alternat Med
. 2014;2014:707908.
Bera P, Mukherjee C, Mitra A. Enzymatic production and emission of floral scent volatiles in Jasminum sambac.
Plant Sci
. 2017 Mar;256:25–38.
Xiao KJ, Wang WX, Dai JL, Zhu L. Anti-inflammatory activity and chemical composition of the essential oils from Senecio flammeus.
. 2014 Jul;13:782–91.
Kim MG, Kim SM, Min JH, Kwon OK, Park MH, Park JW, et al. Anti-inflammatory effects of linalool on ovalbumin-induced pulmonary inflammation.
Int Immunopharmacol
. 2019 Sep;74:105706.
Vandewalle J, Luypaert A, De Bosscher K, Libert C. Therapeutic Mechanisms of Glucocorticoids.
Trends Endocrinol Metab
. 2018 Jan;29(1):42–54.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.